发明名称 |
ANTI-PCSK9 INHIBITORY ANTIBODIES FOR TREATING PATIENTS WITH HYPERLIPIDEMIA UNDERGOING LIPOPROTEIN APHERESIS |
摘要 |
The present invention provides methods for reducing or eliminating a patient's need for lipoprotein apheresis therapy. The methods of the present invention comprise administering to a patient a pharmaceutical composition comprising a PCSK9 inhibitor. In certain embodiments, the PCSK9 inhibitor is an anti-PCSK9 antibody. The methods of the present invention are useful for treating patients with hyperlipidemia and related conditions who are currently being treated with a therapeutic regimen comprising lipoprotein apheresis (e.g., LDL apheresis or Lp(a) apheresis). |
申请公布号 |
WO2017031151(A1) |
申请公布日期 |
2017.02.23 |
申请号 |
WO2016US47257 |
申请日期 |
2016.08.17 |
申请人 |
REGENERON PHARMACEUTICALS, INC. |
发明人 |
PORDY, Robert C.;MANVELIAN, Garen |
分类号 |
C07K16/40;A61K39/00;A61K39/395;A61P3/06 |
主分类号 |
C07K16/40 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|